HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ELV

Elevance Health, Inc. (NYSE)

Healthcare — Healthcare Plans

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Buy 1.8 / 5 21 analysts
$416.19
+$29.46 (+7.62%)
Target: $418.67 (0.6%)
Sign in to add ELV to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$90.38B
P/E Ratio (TTM)17.64
Forward P/E14.19
EPS (TTM)$23.60
Dividend Yield1.65%
Profit Margin2.62%
Revenue Growth2.60%
ROE12.09%
Debt/Equity72.30
Recommendation Buy 1.8
Analyst Target$418.67
Analysts21
Indexes NYSE

Technical Indicators

RSI (14)56.3
Beta0.68
SMA 20-
SMA 40-
52-Week High$426.98
52-Week Low$273.71
50-Day Avg$387.00
200-Day Avg$344.43
Avg Volume$1.75M
Volume$1.56M

Performance Analysis

BULLISH

ELV shows predominantly bullish signals based on its fundamentals and technicals.

- Trading near its 52-week high ($426.98), which may indicate limited upside.
+ RSI at 56.3 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 2.6% year-over-year.
+ Wall Street consensus is "Buy" from 21 analysts.
+ Average analyst target of $418.67 implies 0.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:07 UTC

Back to Screener Export Report